Healthcare
AstraZeneca and Oracle explore AI for trial recruitment and patient care
The companies will test AI for trial recruitment and continuous learning across care and research, with Abu Dhabi among the initial implementation settings.
AstraZeneca and Oracle are investigating whether AI and real-world data can help medical teams identify clinical-trial candidates earlier. Their proposed model would allow providers to find suitable patients more efficiently and potentially connect research with routine healthcare delivery. The initial focus includes cardiovascular, renal and metabolic conditions, with additional areas such as oncology, rare diseases, respiratory illness and immunology under consideration. The organizations also plan to examine a continuous-learning structure in which data from day-to-day care and formal research supports patient management, safety oversight and future protocol design. The collaboration is relevant to healthcare systems because patient recruitment remains a major obstacle in clinical research, while fragmented evidence can slow decisions in care. The Abu Dhabi work is part of the same wider collaboration and adds a GCC-based implementation setting to the companies’ international plans. The source does not describe a deployed product, completed trial or verified clinical improvement; instead, it reports an agreement to test possible applications. Its practical importance is therefore the planned integration of AI, cloud infrastructure, clinical data and research workflows, with potential benefits for trial access and more evidence-informed treatment decisions.
Original source: Yahoo Finance